Acrivon Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner PERCEPTIVE ADVISORS LLC
Acrivon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(17.4%),Joseph Edelman(17.4%), etc.
Acrivon Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(27.1%),Peter Kolchinsky(27.1%), etc.
Acrivon Therapeutics | 8-K: Current report
Acrivon Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Acrivon Therapeutics | 8-K: Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Acrivon Therapeutics | 10-K: Annual report
Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Palani Santhosh
Acrivon Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Palani Santhosh
Acrivon Therapeutics | 8-K: Current report
Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Masson Kristina
Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Mary
Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Holm-Jorgensen Rasmus
Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Devroe Eric
Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gamelin Erick
Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Blume-Jensen Peter
Acrivon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(13.6%),Joseph Edelman(13.6%), etc.
Acrivon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(7.4%),Citadel Advisors Holdings LP(7.4%), etc.
No Data